Drug Safety Newsletter – Edition 116 – 24 September 2024
24/09/2024
Medicines for human use
Safety update
The latest edition of the HPRA newsletter (edition 116) includes important updates to support the safe and appropriate use of the following medicines:
Chlorhexidine: Inadvertent ocular exposure during surgical site preparation
Availability of Educational Materials for Valproate (Epilim) and Topiramate (Topamax)
Product information updates recommended by the EMA's Pharmacovigilance Risk Assessment Committee (PRAC)
Direct Healthcare Professional Communications published on the HPRA website since the last Drug Safety Newsletter
The Importance of Reports of Suspected Adverse Reactions to Pharmacovigilance.